1. Emerging techniques in the minimally invasive treatment and management of thoracic spine tumors

   • Zachary A. Smith
   • Isaac Yang
   • Larry T. Khoo

   Topic Review 18 November 2011 Pages: 443 - 455

   

2. Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs

   • Yuejun Fu
   • Na An
   • Aihua Liang

   Topic Review 23 November 2011 Pages: 457 - 462

3. Targeting DNA repair and the cell cycle in glioblastoma

   • Brian M. Alexander
   • Nancy Pinnell
   • Alan D’Andrea

   Topic Review 24 November 2011 Pages: 463 - 477

   

4. F10 gene hypomethylation, a putative biomarker for glioma prognosis

   • Xiaoping Liu
   • Hailin Tang
   • Guiyuan Li

   Laboratory Investigation - Human/Animal Tissue 13 December 2011 Pages: 479 - 485

   

5. Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway

   • Ke Sai
   • Shuzhen Wang
   • Howard Colman

   Laboratory Investigation 17 January 2012 Pages: 487 - 501

   

6. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells

   • K. Bajbouj
   • C. Mawrin
   • R. Schneider-Stock

   Laboratory Investigation 20 January 2012 Pages: 503 - 516

   

7. Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells

   • Sujatha Venkataraman
   • Irina Alimova
   • Rajeev Vibhakar

   Laboratory Investigation 15 January 2012 Pages: 517 - 526

   

8. Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas

   • Cécile Colavolpe
   • Philippe Metellus
   • Eric Guedj

   Clinical Study - Patient Study 15 December 2011 Pages: 527 - 535

   

9. Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours

   • Michelangelo Bartolo
   • Chiara Zucchella
   • Francesco Pierelli

   Clinical Study - Patient Study 29 November 2011 Pages: 537 - 544

10. Unrecognized visual field deficits in children with primary central nervous system brain tumors

    • M. J. Harbert
    • L. A. Yeh-Nayre
    • J. R. Crawford

    Clinical Study - Patient Study 04 December 2011 Pages: 545 - 549

    

11. Stereotactic radiosurgery for primary and metastatic sarcomas involving the spine

    • U. K. Chang
    • W. I. Cho
    • D. G. Jeon

    Clinical Study - Patient Study 15 January 2012 Pages: 551 - 557

    

12. Expression of RECK in endothelial cells of glioma: comparison with CD34 and VEGF expressions

    • Nunung Nur Rahmah
    • Keiichi Sakai
    • Kazuhiro Hongo

    Clinical Study - Patient Study 20 December 2011 Pages: 559 - 564

    

13. Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas

    • Rohit R. Das
    • Elinor Artsy
    • Jong Woo Lee

    Clinical Study - Patient Study 03 January 2012 Pages: 565 - 570

14. Use of recombinant tissue plasminogen activator in cancer patients with acute stroke

    • Jerome J. Graber
    • Lakshmi Nayak
    • Lisa M. DeAngelis

    Clinical Study - Patient Study 18 December 2011 Pages: 571 - 573

15. Secondary intramedullary spinal cord non-Hodgkin’s lymphoma

    • Eoin P. Flanagan
    • Brian Patrick O’Neill
    • B. Mark Keegan

    Clinical Study 22 December 2011 Pages: 575 - 580

    

16. Contribution of CSF cytology in the diagnostic work-up of breast cancer patients with neurological symptoms: a retrospective analysis over two decades

    • C. A. P. Wauters
    • J. Poelen
    • P. Wesseling

    Clinical Study 04 January 2012 Pages: 581 - 589

    

17. Characterization and outcomes of optic nerve gliomas: a population-based analysis

    • Mark V. Mishra
    • David W. Andrews
    • Yaacov Richard Lawrence

    Clinical Study 12 January 2012 Pages: 591 - 597

    

18. Risk of ischemia in glioma surgery: comparison of first and repeat procedures

    • Stephan Dützmann
    • Florian Geßler
    • Christian Senft

    Clinical Study 17 January 2012 Pages: 599 - 607

    

19. Physiological ¹⁸F-FDG uptake by the spinal cord: is it a point of consideration for cancer patients?

    • Amr Amin
    • Sandra J. Rosenbaum
    • Andreas Bockisch

    Clinical Study 17 January 2012 Pages: 609 - 615

    

20. MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors

    • Marta Mellai
    • Oriana Monzeglio
    • Davide Schiffer

    Clinical Study 28 January 2012 Pages: 617 - 631

    

21. Lexical access speed is significantly correlated with the return to professional activities after awake surgery for low-grade gliomas

    • Sylvie Moritz-Gasser
    • Guillaume Herbet
    • Hugues Duffau

    Clinical Study 24 January 2012 Pages: 633 - 641

    

22. Clinicopathologic and genomic features of gliosarcomas

    • Dakeun Lee
    • So Young Kang
    • Do-Hyun Nam

    Clinical Study 20 January 2012 Pages: 643 - 650

    

23. Spurious progression in pediatric brain tumors

    • Sheema Chawla
    • David N. Korones
    • Louis S. Constine

    Clinical Study 12 January 2012 Pages: 651 - 657

    

24. Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report

    • Jaclyn J. Renfrow
    • Alisha DeTroye
    • Glenn J. Lesser

    Case Report 17 January 2012 Pages: 659 - 663

    

25. Erratum to: The genotoxic effect of radiofrequency waves on mouse brain

    • Emin Karaca
    • Burak Durmaz
    • Ozgur Cogulu

    Erratum 21 March 2012 Pages: 665 - 665